Neogen Corporation reported $870M of revenue over the trailing twelve months, −2.7% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $870M (to Q4 2026). Net income: −$7.9M, trailing twelve months to Q4 2026. Free cash flow: $32M, trailing twelve months to Q4 2026. Operating margin: −2.6%, trailing twelve months to Q4 2026.

NEOGNeogen Corporation

Healthcare

$11.85+111% 1Y

$11.85

$5.3652 weeks$13.99

NEOG as reported

Neogen Corporation reported $870M of revenue over the trailing twelve months, −2.7% on the year before. 11 reported series are charted on this page, each one as filed.

$870M

Revenue, trailing twelve months · to Q4 2026 · −2.7% against the twelve months before

Net income: −$7.9M
Net income · −99% year on year · trailing twelve months to Q4 2026
Free cash flow: $32M
Free cash flow · −169% year on year · trailing twelve months to Q4 2026
Operating margin: −2.6%
Operating margin · trailing twelve months to Q4 2026

Details›

Every series Ryufin has for NEOG, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$870M	−2.7%	Q4 2026
Net income	−$7.9M	−99%	Q4 2026
EPS	−$0.04	−99%	Q4 2026
Gross margin	47%	n/a	Q4 2026
Operating margin	−2.6%	n/a	Q4 2026
Net margin	−0.70%	n/a	Q4 2026
ROE	−27%	n/a	Q4 2026
ROA	−17%	n/a	Q4 2026
ROIC	−13%	n/a	Q4 2026
Free cash flow	$32M	−169%	Q4 2026
P/E	68.4	n/a	Q1 2023 · 15 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.